COMPANY

Doron Therapeutics

Doron Therapeutics is a clinical-stage biotechnology company that has developed a Phase 3 ready, intra-articular biologic drug derived from placental tissue. From company website Source · Oct 12, 2026

Keywords: Knee Osteoarthritis PTP-01

Profile checked Oct 10, 2026

1Trials (company is sponsor)

Timeline

Oct 14, 2025 Trial start Phase 3: A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients source ↗

Upcoming milestones

2027-04 (ESTIMATED) · Phase 3 · A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients · NCT07219771

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT07219771	A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients	Phase 3	Recruiting	Oct 14, 2025	2027-04 (estimated)